If you ask Josh Wolfe, the cofounder and managing partner at science and tech-focused VC firm Lux Capital, the future will look like the stuff of science fiction—a Shazam app on your iPhone, but for detecting smells, or using computers to program cells for specific functions. Now, Lux just raised its largest-ever single fund to invest in those cutting-edge types of technologies—including not-your-typical A.I. startups.
Wolfe says he wants to use the fresh funds to invest in (among other things like aerospace and defense) a host of artificial intelligence’s possible uses, “particularly in these verticals like biology and drug discovery and what we call the tech of science—applying all of these tools and software to increase the productivity of scientific researchers,” he told me on Friday.
